UniProt ID | FRS2_HUMAN | |
---|---|---|
UniProt AC | Q8WU20 | |
Protein Name | Fibroblast growth factor receptor substrate 2 | |
Gene Name | FRS2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 508 | |
Subcellular Localization | Endomembrane system. Cytoplasmic, membrane-bound. | |
Protein Description | Adapter protein that links activated FGR and NGF receptors to downstream signaling pathways. Plays an important role in the activation of MAP kinases and in the phosphorylation of PIK3R1, the regulatory subunit of phosphatidylinositol 3-kinase, in response to ligand-mediated activation of FGFR1. Modulates signaling via SHC1 by competing for a common binding site on NTRK1.. | |
Protein Sequence | MGSCCSCPDKDTVPDNHRNKFKVINVDDDGNELGSGIMELTDTELILYTRKRDSVKWHYLCLRRYGYDSNLFSFESGRRCQTGQGIFAFKCARAEELFNMLQEIMQNNSINVVEEPVVERNNHQTELEVPRTPRTPTTPGFAAQNLPNGYPRYPSFGDASSHPSSRHPSVGSARLPSVGEESTHPLLVAEEQVHTYVNTTGVQEERKNRTSVHVPLEARVSNAESSTPKEEPSSIEDRDPQILLEPEGVKFVLGPTPVQKQLMEKEKLEQLGRDQVSGSGANNTEWDTGYDSDERRDAPSVNKLVYENINGLSIPSASGVRRGRLTSTSTSDTQNINNSAQRRTALLNYENLPSLPPVWEARKLSRDEDDNLGPKTPSLNGYHNNLDPMHNYVNTENVTVPASAHKIEYSRRRDCTPTVFNFDIRRPSLEHRQLNYIQVDLEGGSDSDNPQTPKTPTTPLPQTPTRRTELYAVIDIERTAAMSNLQKALPRDDGTSRKTRHNSTDLPM | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | N-myristoyl glycine | ------MGSCCSCPD ------CCCCCCCCC | 29.41 | - | |
2 | Myristoylation | ------MGSCCSCPD ------CCCCCCCCC | 29.41 | 10092678 | |
4 | S-palmitoylation | ----MGSCCSCPDKD ----CCCCCCCCCCC | 1.31 | 31184863 | |
5 | S-palmitoylation | ---MGSCCSCPDKDT ---CCCCCCCCCCCC | 5.13 | 31184863 | |
35 | Phosphorylation | DDGNELGSGIMELTD CCCCEECCCEEEECC | 37.46 | 28102081 | |
41 | Phosphorylation | GSGIMELTDTELILY CCCEEEECCCEEEEE | 27.80 | 28102081 | |
43 | Phosphorylation | GIMELTDTELILYTR CEEEECCCEEEEEEC | 27.70 | 28102081 | |
48 | Phosphorylation | TDTELILYTRKRDSV CCCEEEEEECCCCCC | 9.48 | 28102081 | |
49 | Phosphorylation | DTELILYTRKRDSVK CCEEEEEECCCCCCC | 26.69 | 22210691 | |
54 | Phosphorylation | LYTRKRDSVKWHYLC EEECCCCCCCEEEEE | 29.63 | 22210691 | |
59 | Phosphorylation | RDSVKWHYLCLRRYG CCCCCEEEEEHHHHC | 9.67 | - | |
73 | Phosphorylation | GYDSNLFSFESGRRC CCCCCCEEECCCCCC | 31.13 | - | |
76 | Phosphorylation | SNLFSFESGRRCQTG CCCEEECCCCCCCCC | 35.27 | - | |
109 | Phosphorylation | QEIMQNNSINVVEEP HHHHHCCCCCEEECC | 24.08 | 27251275 | |
125 | Phosphorylation | VERNNHQTELEVPRT EECCCCCCEEECCCC | 34.68 | 27273156 | |
132 | Phosphorylation | TELEVPRTPRTPTTP CEEECCCCCCCCCCC | 15.85 | 29255136 | |
135 | Phosphorylation | EVPRTPRTPTTPGFA ECCCCCCCCCCCCCH | 26.62 | 27273156 | |
137 | Phosphorylation | PRTPRTPTTPGFAAQ CCCCCCCCCCCCHHH | 45.04 | 28152594 | |
138 | Phosphorylation | RTPRTPTTPGFAAQN CCCCCCCCCCCHHHC | 23.71 | 27273156 | |
150 | Phosphorylation | AQNLPNGYPRYPSFG HHCCCCCCCCCCCCC | 7.38 | - | |
153 | Phosphorylation | LPNGYPRYPSFGDAS CCCCCCCCCCCCCCC | 9.95 | 23312004 | |
155 | Phosphorylation | NGYPRYPSFGDASSH CCCCCCCCCCCCCCC | 32.69 | 20363803 | |
160 | Phosphorylation | YPSFGDASSHPSSRH CCCCCCCCCCCCCCC | 33.64 | 20363803 | |
161 | Phosphorylation | PSFGDASSHPSSRHP CCCCCCCCCCCCCCC | 40.93 | 23312004 | |
164 | Phosphorylation | GDASSHPSSRHPSVG CCCCCCCCCCCCCCC | 34.28 | 28857561 | |
165 | Phosphorylation | DASSHPSSRHPSVGS CCCCCCCCCCCCCCC | 38.77 | 23312004 | |
169 | Phosphorylation | HPSSRHPSVGSARLP CCCCCCCCCCCCCCC | 32.74 | 26670566 | |
172 | Phosphorylation | SRHPSVGSARLPSVG CCCCCCCCCCCCCCC | 14.20 | 27794612 | |
177 | Phosphorylation | VGSARLPSVGEESTH CCCCCCCCCCCCCCC | 47.55 | 30266825 | |
182 | Phosphorylation | LPSVGEESTHPLLVA CCCCCCCCCCCEEEE | 27.93 | 30266825 | |
183 | Phosphorylation | PSVGEESTHPLLVAE CCCCCCCCCCEEEEE | 30.69 | 30266825 | |
195 | Phosphorylation | VAEEQVHTYVNTTGV EEEEEEHHHCCCCCC | 30.24 | 28348404 | |
196 | Phosphorylation | AEEQVHTYVNTTGVQ EEEEEHHHCCCCCCC | 4.10 | 25884760 | |
200 | Phosphorylation | VHTYVNTTGVQEERK EHHHCCCCCCCHHHC | 30.10 | - | |
210 | Phosphorylation | QEERKNRTSVHVPLE CHHHCCCCEEECCCE | 44.48 | 30266825 | |
211 | Phosphorylation | EERKNRTSVHVPLEA HHHCCCCEEECCCEE | 13.64 | 30266825 | |
221 | Phosphorylation | VPLEARVSNAESSTP CCCEEECCCCCCCCC | 25.43 | 30278072 | |
225 | Phosphorylation | ARVSNAESSTPKEEP EECCCCCCCCCCCCC | 36.78 | 29255136 | |
226 | Phosphorylation | RVSNAESSTPKEEPS ECCCCCCCCCCCCCC | 39.99 | 29255136 | |
227 | Phosphorylation | VSNAESSTPKEEPSS CCCCCCCCCCCCCCC | 47.89 | 29255136 | |
233 | Phosphorylation | STPKEEPSSIEDRDP CCCCCCCCCCCCCCC | 47.42 | 28857561 | |
234 | Phosphorylation | TPKEEPSSIEDRDPQ CCCCCCCCCCCCCCC | 40.49 | 25849741 | |
256 | Phosphorylation | VKFVLGPTPVQKQLM CEEEECCCHHHHHHH | 34.00 | 28674419 | |
267 | Ubiquitination | KQLMEKEKLEQLGRD HHHHHHHHHHHHCCC | 69.28 | - | |
277 | Phosphorylation | QLGRDQVSGSGANNT HHCCCCCCCCCCCCC | 22.93 | 29978859 | |
279 | Phosphorylation | GRDQVSGSGANNTEW CCCCCCCCCCCCCCC | 27.50 | 29978859 | |
284 | Phosphorylation | SGSGANNTEWDTGYD CCCCCCCCCCCCCCC | 37.96 | 23663014 | |
288 | Phosphorylation | ANNTEWDTGYDSDER CCCCCCCCCCCCHHC | 38.42 | 23663014 | |
290 | Phosphorylation | NTEWDTGYDSDERRD CCCCCCCCCCHHCCC | 17.86 | 23663014 | |
292 | Phosphorylation | EWDTGYDSDERRDAP CCCCCCCCHHCCCCC | 32.65 | 30266825 | |
300 | Phosphorylation | DERRDAPSVNKLVYE HHCCCCCCHHHHHHH | 39.79 | 27259358 | |
306 | Phosphorylation | PSVNKLVYENINGLS CCHHHHHHHCCCCCC | 17.44 | 21945579 | |
313 | Phosphorylation | YENINGLSIPSASGV HHCCCCCCCCCCCCC | 33.57 | 21945579 | |
316 | Phosphorylation | INGLSIPSASGVRRG CCCCCCCCCCCCCCC | 33.14 | 21945579 | |
318 | Phosphorylation | GLSIPSASGVRRGRL CCCCCCCCCCCCCCC | 42.00 | 21945579 | |
326 | Phosphorylation | GVRRGRLTSTSTSDT CCCCCCCCCCCCCCC | 28.70 | 30576142 | |
327 | Phosphorylation | VRRGRLTSTSTSDTQ CCCCCCCCCCCCCCC | 25.59 | 27273156 | |
328 | Phosphorylation | RRGRLTSTSTSDTQN CCCCCCCCCCCCCCC | 30.68 | 21955146 | |
329 | O-linked_Glycosylation | RGRLTSTSTSDTQNI CCCCCCCCCCCCCCC | 26.19 | 31492838 | |
329 | Phosphorylation | RGRLTSTSTSDTQNI CCCCCCCCCCCCCCC | 26.19 | 25884760 | |
330 | Phosphorylation | GRLTSTSTSDTQNIN CCCCCCCCCCCCCCC | 30.61 | 28985074 | |
331 | Phosphorylation | RLTSTSTSDTQNINN CCCCCCCCCCCCCCC | 38.13 | 30576142 | |
333 | Phosphorylation | TSTSTSDTQNINNSA CCCCCCCCCCCCCHH | 24.23 | 22210691 | |
339 | Phosphorylation | DTQNINNSAQRRTAL CCCCCCCHHHHHHHH | 22.69 | 30177828 | |
344 | Phosphorylation | NNSAQRRTALLNYEN CCHHHHHHHHHCCCC | 24.68 | 28796482 | |
349 | Phosphorylation | RRTALLNYENLPSLP HHHHHHCCCCCCCCC | 13.23 | 20007894 | |
354 | Phosphorylation | LNYENLPSLPPVWEA HCCCCCCCCCCHHHH | 57.59 | 26356563 | |
365 | Phosphorylation | VWEARKLSRDEDDNL HHHHHHCCCCCCCCC | 40.49 | 28355574 | |
378 | Phosphorylation | NLGPKTPSLNGYHNN CCCCCCCCCCCCCCC | 39.43 | 26356563 | |
392 | Phosphorylation | NLDPMHNYVNTENVT CCCCCCCCCCCCCCE | 4.76 | 25884760 | |
395 | Phosphorylation | PMHNYVNTENVTVPA CCCCCCCCCCCEEEC | 20.92 | - | |
403 | Phosphorylation | ENVTVPASAHKIEYS CCCEEECCCCCCEEE | 25.49 | 25884760 | |
428 | Phosphorylation | NFDIRRPSLEHRQLN EEECCCCCCCCCCCC | 44.57 | 30266825 | |
436 | Phosphorylation | LEHRQLNYIQVDLEG CCCCCCCEEEEECCC | 11.00 | 9632781 | |
436 | Dephosphorylation | LEHRQLNYIQVDLEG CCCCCCCEEEEECCC | 11.00 | 9632781 | |
445 | Phosphorylation | QVDLEGGSDSDNPQT EEECCCCCCCCCCCC | 44.81 | 28348404 | |
447 | Phosphorylation | DLEGGSDSDNPQTPK ECCCCCCCCCCCCCC | 40.77 | 30278072 | |
455 | Phosphorylation | DNPQTPKTPTTPLPQ CCCCCCCCCCCCCCC | 27.37 | 27732954 | |
457 | Phosphorylation | PQTPKTPTTPLPQTP CCCCCCCCCCCCCCC | 46.40 | 25159151 | |
458 | Phosphorylation | QTPKTPTTPLPQTPT CCCCCCCCCCCCCCC | 24.83 | 25159151 | |
463 | Phosphorylation | PTTPLPQTPTRRTEL CCCCCCCCCCCCCEE | 25.37 | 25159151 | |
465 | Phosphorylation | TPLPQTPTRRTELYA CCCCCCCCCCCEEEE | 35.85 | 27732954 | |
468 | Phosphorylation | PQTPTRRTELYAVID CCCCCCCCEEEEEEE | 27.35 | 20068231 | |
471 | Phosphorylation | PTRRTELYAVIDIER CCCCCEEEEEEEHHH | 7.81 | 25884760 | |
479 | Phosphorylation | AVIDIERTAAMSNLQ EEEEHHHHHHHHHHH | 13.13 | 20068231 | |
483 | Phosphorylation | IERTAAMSNLQKALP HHHHHHHHHHHHHCC | 29.66 | 20068231 | |
495 | Phosphorylation | ALPRDDGTSRKTRHN HCCCCCCCCCCCCCC | 32.14 | 24702127 | |
496 | Phosphorylation | LPRDDGTSRKTRHNS CCCCCCCCCCCCCCC | 36.99 | 24702127 | |
499 | Phosphorylation | DDGTSRKTRHNSTDL CCCCCCCCCCCCCCC | 35.73 | 29514088 | |
503 | Phosphorylation | SRKTRHNSTDLPM-- CCCCCCCCCCCCC-- | 19.71 | 22617229 | |
504 | Phosphorylation | RKTRHNSTDLPM--- CCCCCCCCCCCC--- | 47.04 | 28985074 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
196 | Y | Phosphorylation | Kinase | FGFR1 | P11362 | Uniprot |
306 | Y | Phosphorylation | Kinase | FGFR1 | P11362 | Uniprot |
349 | Y | Phosphorylation | Kinase | FGFR1 | P11362 | Uniprot |
392 | Y | Phosphorylation | Kinase | FGFR1 | P11362 | Uniprot |
436 | Y | Phosphorylation | Kinase | FGFR1 | P11362 | Uniprot |
471 | Y | Phosphorylation | Kinase | FGFR1 | P11362 | Uniprot |
- | K | Ubiquitination | E3 ubiquitin ligase | CBL | P22681 | PMID:11997436 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FRS2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FRS2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PTN11_HUMAN | PTPN11 | physical | 10650943 | |
GRB2_HUMAN | GRB2 | physical | 8780727 | |
GRB2_HUMAN | GRB2 | physical | 11997436 | |
SOS1_HUMAN | SOS1 | physical | 11997436 | |
CBL_HUMAN | CBL | physical | 11997436 | |
NTRK1_HUMAN | NTRK1 | physical | 10092678 | |
NTRK2_HUMAN | NTRK2 | physical | 10092678 | |
NTRK3_HUMAN | NTRK3 | physical | 10092678 | |
RET_HUMAN | RET | physical | 11360177 | |
PTN11_HUMAN | PTPN11 | physical | 11360177 | |
PTN11_HUMAN | PTPN11 | physical | 9632781 | |
CBL_HUMAN | CBL | physical | 17944804 | |
FLOT1_HUMAN | FLOT1 | physical | 22235335 | |
SRBS1_HUMAN | SORBS1 | physical | 22235335 | |
SPY2_HUMAN | SPRY2 | physical | 15004239 | |
GRB2_HUMAN | GRB2 | physical | 15004239 | |
GRB2_HUMAN | GRB2 | physical | 22974441 | |
PTN11_HUMAN | PTPN11 | physical | 22974441 | |
GRB2_HUMAN | GRB2 | physical | 16893902 | |
SOS1_HUMAN | SOS1 | physical | 16893902 | |
BECN1_HUMAN | BECN1 | physical | 25814554 | |
RS6_HUMAN | RPS6 | physical | 25814554 | |
GRB2_HUMAN | GRB2 | physical | 25159185 | |
PTN11_HUMAN | PTPN11 | physical | 25159185 | |
PTN11_MOUSE | Ptpn11 | physical | 25159185 | |
GRB2_MOUSE | Grb2 | physical | 25159185 | |
GAB1_MOUSE | Gab1 | physical | 25159185 | |
FGFR2_HUMAN | FGFR2 | physical | 15629145 | |
EPHA4_HUMAN | EPHA4 | physical | 16365308 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Myristoylation | |
Reference | PubMed |
"The signaling adapter FRS-2 competes with Shc for binding to thenerve growth factor receptor TrkA. A model for discriminatingproliferation and differentiation."; Meakin S.O., MacDonald J.I.S., Gryz E.A., Kubu C.J., Verdi J.M.; J. Biol. Chem. 274:9861-9870(1999). Cited for: INTERACTION WITH CKS2; GRB2; PTPN11; SRC; NTRK1; NTRK2 AND NTRK3,MYRISTOYLATION AT GLY-2, PHOSPHORYLATION AT TYROSINE RESIDUES, ANDTISSUE SPECIFICITY. | |
"Novel recognition motif on fibroblast growth factor receptor mediatesdirect association and activation of SNT adapter proteins."; Xu H., Lee K.W., Goldfarb M.P.; J. Biol. Chem. 273:17987-17990(1998). Cited for: NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH FGFR1, MYRISTOYLATION ATGLY-2, AND PHOSPHORYLATION AT TYROSINE RESIDUES. |